ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 667707 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 667707; 2) Community: the network communities that were significantly associated with the response to NSC 667707; 3) Molecule: the relationships between components within communities and NSC 667707; 4) MDR: the compounds that were significantly associated with the NSC 667707.

NSC Compound Enrichment Correlation
NSC 71669 Null 0.017498903403062 0.31695133
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.017498903403062 0.19274934
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.017498903403062 0.43823928
NSC 736811 Null 0.017498903403062 0.39340502
NSC 740 Methotrexate 0.017498903403062 0.53097348
NSC 740476 Null 0.017498903403062 0.38090797
NSC 746053 Null 0.017498903403062 0.28081922
NSC 756404 GW843682X 0.017498903403062 0.379853
NSC 87868 2-Phenylethyl isothiocyanate 0.017498903403062 0.3209804
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0174989034030623 0.31872866
Total:94  Current:42    [First] [Prev] [Next] [Last]